Study on the Hemodynamic Effects of Cipofol Intravenous Anesthesia in Patients undergoing Transsphenoidal Surgery for Pituitary Adenoma

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500097056

Enrollment

Unknown

Registered

2025-02-11

Start date

2025-02-11

Completion date

Unknown

Last updated

2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Adenoma

Interventions

Ciprofol group (experimental group) :TIVA based on ciprofol

Propofol group (control group):TIVA based on propofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 18~65 years old; ASA1-3 grades, patients undergoing endoscopic transnasal pituitary tumor resection.

Exclusion criteria

Exclusion criteria: 1. Heart, lung, liver and kidney dysfunction, obesity BMI greater than 28; 2. People who are allergic to research drugs; 3. It is not expected that the tracheal catheter can be removed after the operation.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;heart rate;Stroke volume;Peripheral resistance;	—

Secondary

Measure	Time frame
the numbers of Arrhythmia;Electrocardiogram after surgery;baseline map;map of intubation;map of cutting tumor;map of pull out the tube;	—

Countries

China

Contacts

Public ContactWeihua Cui

Beijing Tiantan Hospital, Capital Medical University

weihuacui@ccmu.edu.cn+86 136 5131 5600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026